To test this, we chose CT26 tumor cells known to produce high levels of VEGF-A in vitro (Terme et al., 2013)—similar evidence is provided in Supplementary Figure S5D—to test the impact of PG on VEGF-A. This evidence concerns the gene VEGFA and neoplasm.